PHIO PHARMACEUTICALS CORP. — Revenue by Fiscal Year
8 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d7218fd3-775a-4fcb-a970-4f7e206e9fb4/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001683168-21-001062 |
| FY 2019 | $21.0k | 2019-01-01 – 2019-12-31 | evidence 0001683168-20-000969 |
| FY 2018 | $138.0k | 2018-01-01 – 2018-12-31 | evidence 0001683168-19-000795 |
| FY 2017 | $15.0k | 2017-01-01 – 2017-12-31 | evidence 0001193125-18-096053 |
| FY 2016 | $19.0k | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-102730 |
| FY 2015 | $34.0k | 2015-01-01 – 2015-12-31 | evidence 0001193125-17-102730 |
| FY 2013 | $399.0k | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-121519 |
| FY 2012 | $97.0k | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-133515 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
PHIO PHARMACEUTICALS CORP. — all facts · Net Income · Operating Income